Showing 341 - 360 results of 1,139 for search '"preclinical"', query time: 0.05s Refine Results
  1. 341

    Innovative Approaches to Suppressing Pseudomonas aeruginosa Growth and Virulence: Current Status and Future Directions by Sandip Patil, Xiaowen Chen, Feiqiu Wen

    Published 2024-01-01
    “…Additionally, novel approaches, including RNA interference, CRISPR-Cas systems, and nanotechnology, show promise in preclinical studies. Despite advancements, challenges persist, prompting the need for a multifaceted approach targeting various aspects of P. aeruginosa pathogenesis for effective infection management. …”
    Get full text
    Article
  2. 342

    Bioluminescence in cancer research - Applications and challenges by Shrikant B. Mali

    Published 2024-03-01
    “…Bioluminescence imaging (BLI) is an important technology in preclinical scientific research as well as non-invasive tumour diagnoses. …”
    Get full text
    Article
  3. 343

    Hypertension and Its Impact on Stroke Recovery: From a Vascular to a Parenchymal Overview by Benjamin Maïer, Nathalie Kubis

    Published 2019-01-01
    “…This attractive topic remains a focus of continued investigation and stresses the relevance of including this vascular risk factor in preclinical investigations of stroke outcome.…”
    Get full text
    Article
  4. 344

    Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus by Chelsea A. Vadnie, Colleen A. McClung

    Published 2017-01-01
    “…Here, we review clinical and preclinical studies that provide evidence both for and against a causal role for the SCN in mood disorders.…”
    Get full text
    Article
  5. 345

    Oncolytic Immunotherapy: Where Are We Clinically? by Akseli Hemminki

    Published 2014-01-01
    “…Following a century of preclinical and clinical work, oncolytic viruses are now proving themselves in randomized phase 3 trials. …”
    Get full text
    Article
  6. 346

    Characterisation of Chemical Constitutes and Spermatogenic Activity of Ushir (Vetiveria Zizanioides Linn) versus Ikshu (Saccharum Officinarum Linn) in Male Wistar Rats: A Research... by Akshay Sudhir Pargaonkar, Jaymala Jadhav, Bhagyashree Ratan Jibkate, Minakshi Urkude

    Published 2025-01-01
    “…Standardisation of Ayurvedic medicines at the pharmaceutical and analytical levels is important for proceeding with preclinical or clinical studies. The outcomes of animal research have helped consider the drug’s benefits and drawbacks. …”
    Get full text
    Article
  7. 347

    The Role of Pentacyclic Triterpenoids in Non-Small Cell Lung Cancer: The Mechanisms of Action and Therapeutic Potential by Young-Shin Lee, Ryuk Jun Kwon, Hye Sun Lee, Jae Heun Chung, Yun Seong Kim, Han-Sol Jeong, Su-Jung Park, Seung Yeon Lee, Taehwa Kim, Seong Hoon Yoon

    Published 2024-12-01
    “…However, despite promising preclinical data, rigorous clinical trials are needed to verify their safety and efficacy. …”
    Get full text
    Article
  8. 348
  9. 349
  10. 350

    TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers by Kimberly J. Briggs, Kevin M. Cottrell, Matthew R. Tonini, Alice Tsai, Minjie Zhang, Douglas A. Whittington, Wenhai Zhang, Steven A. Lombardo, Satoshi Yoda, Erik W. Wilker, Samuel R. Meier, Yi Yu, Teng Teng, Alan Huang, John P. Maxwell

    Published 2025-02-01
    “…In this study, we demonstrate that TNG908 selectively binds the PRMT5·MTA complex driving selective inhibition of PRMT5 in MTAP-null cancers, a mechanism that creates a large therapeutic index relative to first generation PRMT5 inhibitors that have alternative binding mechanisms that are not tumor-selective. Strong preclinical activity in multiple MTAP-deleted xenograft models, as well as demonstrated brain penetrance in preclinical models, support the potential for histology-agnostic clinical development of TNG908 in MTAP-deleted solid tumors, including CNS malignancies. …”
    Get full text
    Article
  11. 351

    First-in-Men Online Adaptive Robotic Stereotactic Body Radiation Therapy: Toward Ultrahypofractionation for High-Risk Prostate Cancer Patients by Victor J. Brand, MD, Maaike T.W. Milder, PhD, Miranda E.M.C. Christianen, MD, PhD, Kim C. de Vries, MD, Mischa S. Hoogeman, PhD, Luca Incrocci, MD, PhD, Femke E. Froklage, MD, PhD

    Published 2025-02-01
    “…This paper focuses on the development, preclinical validation, and clinical testing of online adaptive robotic stereotactic body radiation therapy for this patient group. …”
    Get full text
    Article
  12. 352
  13. 353

    Prediction and verification of the influence of the rs367781716 SN P on the interaction of ТАТА -binding protein with the promoter of the human АВСА9 gene by O. V. Arkova, I. A. Drachkova, T. V. Arshinova, D. A. Rasskazov, V. V. Suslov, P. M. Ponomarenko, M. P. Ponomarenko, N. A. Kolchanov, L. K. Savinkova

    Published 2016-01-01
    “…This approach contributes to undervaluation of clinically relevant SNPs and to unnecessary computational expenses (on verification of neutral SNPs). Preclinical empirical verification of possible candidate SNP markers may eliminate neutral SNPs from the dataset. …”
    Get full text
    Article
  14. 354

    Assessment of phytochemical screening, antibacterial, analgesic, and antipyretic potentials of Litsea glutinosa (L.) leaves extracts in a mice model. by Zubair Khalid Labu, Samira Karim, Md Tarekur Rahman, Md Imran Hossain, Sarder Arifuzzaman, Md Shakil

    Published 2025-01-01
    “…Additionally, the toxicity of the extracts was evaluated through preclinical testing.<h4>Results</h4>In hot plate method, the highest pain inhibitory activity was found at a dose of 500 mg/kg of crude extract (3.37 ± 0.31 sec) which differed significantly (P < 0.01 and P < 0.001) with that of the standard drug morphine (6.47 ± 0.23 sec). …”
    Get full text
    Article
  15. 355

    IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential by Feiya Sheng, Mi Li, Jia-Mei Yu, Si-Yu Yang, Liang Zou, Guan-Jun Yang, Le-Le Zhang, Le-Le Zhang

    Published 2025-01-01
    “…Although research on the IL-33/ST2 signaling pathway has deepened recently, relevant treatment strategies have been proposed, and even targeted drugs are in the preclinical stage; further research on the effect of the IL-33/ST2 signaling pathway in different diseases is still necessary, to provide a clearer understanding of the different roles of IL-33/ST2 in disease progression and to develop new drugs and treatment strategies. …”
    Get full text
    Article
  16. 356
  17. 357

    Progress in the structural modification and pharmacological activity of isosteviol by Tao Wang, Bowen Pan, Lijuan Liu, Zhangchao Dong, Wenhui Zhang, Xiongwei Liu, Ying Zhou, Yang Shi

    Published 2025-01-01
    “…This article briefly reviews the novel derivatives obtained through structural modification of isosteviol, including their pharmacological activities, to provide a reference for the development of new synthetic strategies and the construction of new isosteviol derivatives, and to guide preclinical studies and development of new drugs with greater pharmacological efficacy.…”
    Get full text
    Article
  18. 358

    Targeting the chemokines in acute graft-versus-host disease by Ziwei Xu, Huafang Wang

    Published 2025-01-01
    “…We also present both preclinical and clinical insights into the application of chemokines in preventing and treating acute GVHD. …”
    Get full text
    Article
  19. 359

    The Regulation of Inflammatory Mediators in Acute Kidney Injury via Exogenous Mesenchymal Stem Cells by Tao Du, Ying-Jian Zhu

    Published 2014-01-01
    “…Exogenous mesenchymal stem cells (MSCs) are now under extensive investigation as a potential therapy for AKI. Various preclinical studies indicated the beneficial effects of MSCs in alleviating renal injury and accelerating tissue repair. …”
    Get full text
    Article
  20. 360

    Twenty-year review of author characteristics and academic articles published in a medical student journal by Lorna Pairman, Angad S Chauhan

    Published 2024-12-01
    “…There was a decline in the proportion of articles authored by preclinical students (from 25% to 6%) and with University of Otago affiliation (from (59% to 28%) when comparing the first and second decades of NZMSJ publication. …”
    Get full text
    Article